464 related articles for article (PubMed ID: 30839392)
1. Evidence for Local and Systemic Immune Activation in Functional Dyspepsia and the Irritable Bowel Syndrome: A Systematic Review.
Burns G; Carroll G; Mathe A; Horvat J; Foster P; Walker MM; Talley NJ; Keely S
Am J Gastroenterol; 2019 Mar; 114(3):429-436. PubMed ID: 30839392
[TBL] [Abstract][Full Text] [Related]
2. Duodenal mastocytosis, eosinophilia and intraepithelial lymphocytosis as possible disease markers in the irritable bowel syndrome and functional dyspepsia.
Walker MM; Talley NJ; Prabhakar M; Pennaneac'h CJ; Aro P; Ronkainen J; Storskrubb T; Harmsen WS; Zinsmeister AR; Agreus L
Aliment Pharmacol Ther; 2009 Apr; 29(7):765-73. PubMed ID: 19183150
[TBL] [Abstract][Full Text] [Related]
3. Proton Pump Inhibitors Reduce Duodenal Eosinophilia, Mast Cells, and Permeability in Patients With Functional Dyspepsia.
Wauters L; Ceulemans M; Frings D; Lambaerts M; Accarie A; Toth J; Mols R; Augustijns P; De Hertogh G; Van Oudenhove L; Tack J; Vanuytsel T
Gastroenterology; 2021 Apr; 160(5):1521-1531.e9. PubMed ID: 33346007
[TBL] [Abstract][Full Text] [Related]
4. The role of mast cells in functional GI disorders.
Wouters MM; Vicario M; Santos J
Gut; 2016 Jan; 65(1):155-68. PubMed ID: 26194403
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic strategies for functional dyspepsia and irritable bowel syndrome based on pathophysiology.
Talley NJ; Holtmann G; Walker MM
J Gastroenterol; 2015 Jun; 50(6):601-13. PubMed ID: 25917563
[TBL] [Abstract][Full Text] [Related]
6. Comparison of pancreatic enzyme abnormalities and protease-activated receptor-2-positive eosinophils in the duodenum of patients with functional dyspepsia-irritable bowel syndrome overlap with functional dyspepsia alone in Asian populations.
Futagami S; Kessoku T; Kasai Y; Higurashi T; Nakajima A; Agawa S; Yamawaki H; Nakamura K; Habiro M; Kawawa R; Ueki N; Higashida S; Watanabe Y; Yamato H; Yamamoto T; Takasaki Y; Ito K; Hojo M; Isayama H; Motoda N; Ohashi R; Siah KTH; Ng CK; Gwee KA
J Gastroenterol Hepatol; 2023 Oct; 38(10):1778-1786. PubMed ID: 37278449
[TBL] [Abstract][Full Text] [Related]
7. Utilising lipid and, arginine and proline metabolism in blood plasma to differentiate the biochemical expression in functional dyspepsia (FD) and irritable bowel syndrome (IBS).
Karpe AV; Liu JW; Shah A; Koloski N; Holtmann G; Beale DJ
Metabolomics; 2022 Jun; 18(6):38. PubMed ID: 35687195
[TBL] [Abstract][Full Text] [Related]
8. Gut microbiota profiles and the role of anti-CdtB and anti-vinculin antibodies in patients with functional gastrointestinal disorders (FGID).
Vasapolli R; Schulz C; Schweden M; Casèn C; Kirubakaran GT; Kirste KH; Macke L; Link A; Schütte K; Malfertheiner P
Eur J Clin Invest; 2021 Dec; 51(12):e13666. PubMed ID: 34390492
[TBL] [Abstract][Full Text] [Related]
9. Small bowel homing T cells are associated with symptoms and delayed gastric emptying in functional dyspepsia.
Liebregts T; Adam B; Bredack C; Gururatsakul M; Pilkington KR; Brierley SM; Blackshaw LA; Gerken G; Talley NJ; Holtmann G
Am J Gastroenterol; 2011 Jun; 106(6):1089-98. PubMed ID: 21245834
[TBL] [Abstract][Full Text] [Related]
10. Overlap of Irritable Bowel Syndrome and Functional Dyspepsia in the Clinical Setting: Prevalence and Risk Factors.
von Wulffen M; Talley NJ; Hammer J; McMaster J; Rich G; Shah A; Koloski N; Kendall BJ; Jones M; Holtmann G
Dig Dis Sci; 2019 Feb; 64(2):480-486. PubMed ID: 30368683
[TBL] [Abstract][Full Text] [Related]
11. Alterations of food antigen-specific serum immunoglobulins G and E antibodies in patients with irritable bowel syndrome and functional dyspepsia.
Zuo XL; Li YQ; Li WJ; Guo YT; Lu XF; Li JM; Desmond PV
Clin Exp Allergy; 2007 Jun; 37(6):823-30. PubMed ID: 17517095
[TBL] [Abstract][Full Text] [Related]
12. The impact of overlapping functional dyspepsia, belching disorders and functional heartburn on anxiety, depression and quality of life of Chinese patients with irritable bowel syndrome.
Yao X; Yang Y; Zhang S; Shi Y; Zhang Q; Wang Y
BMC Gastroenterol; 2020 Jul; 20(1):209. PubMed ID: 32631285
[TBL] [Abstract][Full Text] [Related]
13. Inflammation and Overlap of Irritable Bowel Syndrome and Functional Dyspepsia.
Wang C; Fang X
J Neurogastroenterol Motil; 2021 Apr; 27(2):153-164. PubMed ID: 33795538
[TBL] [Abstract][Full Text] [Related]
14. Duodenal Eosinophils and Mast Cells in Functional Dyspepsia: A Systematic Review and Meta-Analysis of Case-Control Studies.
Shah A; Fairlie T; Brown G; Jones MP; Eslick GD; Duncanson K; Thapar N; Keely S; Koloski N; Shahi M; Walker MM; Talley NJ; Holtmann G
Clin Gastroenterol Hepatol; 2022 Oct; 20(10):2229-2242.e29. PubMed ID: 35123088
[TBL] [Abstract][Full Text] [Related]
15. A cross-sectional study of nausea in functional abdominal pain: relation to mucosal mast cells and psychological functioning.
Friesen C; Singh M; Singh V; Schurman JV
BMC Gastroenterol; 2020 May; 20(1):144. PubMed ID: 32393272
[TBL] [Abstract][Full Text] [Related]
16. Overlap between irritable bowel syndrome and functional dyspepsia including subtype analyses.
Choi YJ; Kim N; Yoon H; Shin CM; Park YS; Kim JW; Kim YS; Lee DH; Jung HC
J Gastroenterol Hepatol; 2017 Sep; 32(9):1553-1561. PubMed ID: 28160607
[TBL] [Abstract][Full Text] [Related]
17. The role of eosinophils and mast cells in intestinal functional disease.
Walker MM; Warwick A; Ung C; Talley NJ
Curr Gastroenterol Rep; 2011 Aug; 13(4):323-30. PubMed ID: 21552990
[TBL] [Abstract][Full Text] [Related]
18. Impacts of the COVID-19 pandemic on functional dyspepsia and irritable bowel syndrome: A population-based survey.
Oshima T; Siah KTH; Yoshimoto T; Miura K; Tomita T; Fukui H; Miwa H
J Gastroenterol Hepatol; 2021 Jul; 36(7):1820-1827. PubMed ID: 33197076
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic yield of alarm features in irritable bowel syndrome and functional dyspepsia.
Hammer J; Eslick GD; Howell SC; Altiparmak E; Talley NJ
Gut; 2004 May; 53(5):666-72. PubMed ID: 15082584
[TBL] [Abstract][Full Text] [Related]
20. [Prevalence of combination of functional dyspepsia and irritable bowel syndrome: a meta-analysis of studies using the Rome III-IV Criteria].
Andreev DN; Bordin DS; Vyuchnova ES; Lebedeva EG; Dicheva DT; Umyarova RM; Maev IV
Ter Arkh; 2022 Oct; 94(9):1099-1108. PubMed ID: 36286762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
